These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 32568174)
1. Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients. Gissi DB; Gabusi A; Tarsitano A; Asioli S; Rossi R; Marchetti C; Montebugnoli L; Foschini MP; Morandi L Cancer Biomark; 2020; 28(4):499-510. PubMed ID: 32568174 [TBL] [Abstract][Full Text] [Related]
2. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel. Morandi L; Gissi D; Tarsitano A; Asioli S; Gabusi A; Marchetti C; Montebugnoli L; Foschini MP Clin Epigenetics; 2017; 9():85. PubMed ID: 28814981 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing. Morandi L; Gissi D; Tarsitano A; Asioli S; Monti V; Del Corso G; Marchetti C; Montebugnoli L; Foschini MP J Craniomaxillofac Surg; 2015 Oct; 43(8):1494-500. PubMed ID: 26302938 [TBL] [Abstract][Full Text] [Related]
4. Cytopathological tests for early detection of oral carcinogenesis. Salgueiro AP; Martelli FT; D'Ávila SR; Milnikel TR; Koehler-Santos P; Maraschin BJ; da Silva VP; Rados PV; Visioli F Eur J Cancer Prev; 2020 Jan; 29(1):73-79. PubMed ID: 30913094 [TBL] [Abstract][Full Text] [Related]
5. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Scheifele C; Schmidt-Westhausen AM; Dietrich T; Reichart PA Oral Oncol; 2004 Sep; 40(8):824-8. PubMed ID: 15288838 [TBL] [Abstract][Full Text] [Related]
6. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma]. Cao J; Jin JQ; Deng DJ; Liu HW Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914 [TBL] [Abstract][Full Text] [Related]
7. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus. Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642 [TBL] [Abstract][Full Text] [Related]
8. Brushing of oral mucosa for diagnosis of HPV infection in patients with potentially malignant and malignant oral lesions. Giovannelli L; Campisi G; Colella G; Capra G; Di Liberto C; Caleca MP; Matranga D; D'Angelo M; Lo Muzio L; Ammatuna P Mol Diagn Ther; 2006; 10(1):49-55. PubMed ID: 16646577 [TBL] [Abstract][Full Text] [Related]
9. A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology. Kolokythas A; Bosman MJ; Pytynia KB; Panda S; Sroussi HY; Dai Y; Schwartz JL; Adami GR J Oral Pathol Med; 2013 Oct; 42(9):663-9. PubMed ID: 23590359 [TBL] [Abstract][Full Text] [Related]
10. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703 [TBL] [Abstract][Full Text] [Related]
12. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Sun L; Feng J; Ma L; Liu W; Zhou Z Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820 [TBL] [Abstract][Full Text] [Related]
13. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression. Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175 [TBL] [Abstract][Full Text] [Related]
14. Overestimated risk of transformation in oral lichen planus. Cai X; Zhang J; Zhang H; Li T Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493 [TBL] [Abstract][Full Text] [Related]
15. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. Ogmundsdóttir HM; Björnsson J; Holbrook WP J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450 [TBL] [Abstract][Full Text] [Related]
16. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566 [TBL] [Abstract][Full Text] [Related]
17. [DNA cytometry of exfoliated cells in the diagnosis of oral potential malignant disorders]. Liu Y; Gao Y; Chen XJ; Hua H Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):16-20. PubMed ID: 30773538 [TBL] [Abstract][Full Text] [Related]
18. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Girod SC; Pfeiffer P; Ries J; Pape HD Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452 [TBL] [Abstract][Full Text] [Related]
19. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway. Liu W; Yao Y; Shi L; Tang G; Wu L J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929 [TBL] [Abstract][Full Text] [Related]